Guillermo Velasco, Jordi Muntané, Magali Humbert, Eva Žerovnik, María Morán, Walter Balduini, Sharon L. McKenna, Paula Ludovico, Tabea Wiedmer, Leopold Eckhart, Bassam Janji, Nikolai Engedal, Aurel Perren, Patricia de la Cruz-Ojeda, Mario P. Tschan, Rupert Langer, Nadezda Apostolova, Belém Sampaio-Marques, Universidade do Minho, Bernese Cancer League, Stiftung für klinisch-experimentelle Tumorforschung, Werner and Hedy Berger-Janser Foundation for Cancer Research, Instituto de Salud Carlos III, European Commission, Ministerio de Ciencia, Innovación y Universidades (España), Agencia Estatal de Investigación (España), Junta de Andalucía, Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (España), Breakthrough Cancer Research (Ireland), Fonds National de la Recherche Luxembourg, Fundação para a Ciência e a Tecnologia (Portugal), Slovenian Research Agency, Recherche Suisse contre le Cancer, Swiss National Science Foundation, Universidad de Sevilla. Departamento de Cirugía, [Humbert,M, Morán,M, Muntané,J, Apostolova,N, McKenna,SL, Velasco,G, Balduini,W, Eckhart,L, Janji,B, Sampaio-Marques,B, Ludovico,P, Zerovnik,E, Engedal,N, Tschan,MP] TRANSAUTOPHAGY: European Network for Multidisciplinary Research and Translation of Autophagy Knowledge, COST Action CA15138, Barcelona, Spain. [Humbert,M, Wiedmer,T, Langer,R, Perren,A, Tschan,MP] Institute of Pathology, University of Bern, Bern, Switzerland. [Morán,M] Mitochondrial and Neuromuscular Diseases Laboratory, Instituto de Investigación Sanitaria Hospital ‘12 de Octubre’ (‘imas12’), Madrid, Spain. [Morán,M] Spanish Network for Biomedical Research in Rare Diseases (CIBERER), U723, Institute of Health Carlos III (ISCIII), Madrid, Spain. [de la Cruz-Ojeda,P, Muntané,J] Institute of Biomedicine of Seville (IBiS), Hospital University 'Virgen del Rocío'/CSIC/University of Seville, Seville, Spain. [de la Cruz-Ojeda,P, Muntané,J] Department of Surgery, School of Medicine, University of Seville, Seville, Spain. [Muntané,J, Apostolova,N] Spanish Network for Biomedical Research in Hepatic and Digestive Diseases (CIBERehd), Institute of Health Carlos III (ISCIII), Madrid, Spain. [Apostolova,N] Department of Pharmacology, University of Valencia, Valencia, Spain. [McKenna,SL] Cancer Research at UCC,Western Gateway Building, University College Cork, Cork, Ireland. [Velasco,G] Department of Biochemistry and Molecular Biology, School of Biology, Complutense University, and Instituto de Investigaciones Sanitarias San Carlos (IdISSC), Madrid, Spain. [Balduini,W] Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy. [Eckhart,L] Department of Dermatology, Medical University of Vienna, Vienna, Austria. [Janji,B] Tumor Immunotherapy and Microenvironment (TIME) Group, Department of Oncology—Luxembourg. Institute of Health, Luxembourg City, Luxembourg. [Sampaio-Marques,B, Ludovico,P] Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal. [Sampaio-Marques,B, Ludovico,P] ICVS/3B’s—PT Government Associate Laboratory, Braga/Guimarães, Portugal. [Zerovnik,E] Department of Biochemistry and Molecular and Structural Biology, Jožef Stefan Institute, Ljubljana, Slovenia. [Engedal,N] Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., This work was supported by grants fromthe Bernese Cancer League, 'Stiftung für klinisch-experimentelle Tumorforschung', and theWerner and Hedy Berger-Janser Foundation for Cancer Research (to M.H.), by Institute of Health Carlos III (ISCIII) and FEDER funds from the EU (PI14/01085 and PI17/00093) and supported by Miguel Servet contract by ISCIII and FSE funds (CPII16/00023) (to M.M.), from the Spanish Ministry of Science, Innovation and Universities (RTI2018-096748-B-100 to N.A.), from the University Professor Training Fellowship, Ministry of Science, Innovation and University, Government of Spain (FPU17/00026) (to P.C.O), from the ISCIII (PI16/00090 and PI19/01266) and the Andalusian Government (Consejería de Igualdad, Salud y Políticas Sociales, PI-0198-2016) for their financial support, and from the Biomedical Research Network Center for Liver and Digestive Diseases (CIBERehd) founded by the ISCIII and co-financed by European Development Regional Fund (EDRF) 'A way to achieve Europe' for their financial support (to J.M.), from Breakthrough Cancer Research, Ireland funding (to S.L.M), from the PI18/00442 grant integrated into the State Plan for R & D + I2013-2016 and funded by the ISCIII and the ERDF, a way to make Europe (to G.V.), from the Luxembourg National Research Fund (C18/BM/12670304/COMBATIC to B.J.), from the Northern Portugal Regional Operational Programme (NORTE 2020), under the Portugal 2020 Partnership Agreement, by the European Regional Development Fund (FEDER), through the Competitiveness Factors Operational Programme (COMPETE) (NORTE-01-0145-FEDER-000013) and from the projects POCI-01-0145-FEDER-028159 and POCI-01-0145-FEDER-030782 by FEDER, through the COMPETE (to P.L.), from National funds, through the Foundation for Science and Technology (FCT) (to P.L.), from ARRS—the Slovenian research agency, programme P1-0140: Proteolysis and its regulation (led by B. Turk) (to E.Ž.), and from the Swiss Cancer Research (KFS-3360-02-2014) (to A.P, and M.P.T.) (KFS-3409-02-2014), and the Swiss National Science Foundation (31003A_173219) (to M.P.T.).